Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids

References

• Adcock, I. M., Caramori, G. (2001). Cross-talk between proinflammatory transcription factors and glucocorticoids. Immunol Cell Biol 79:376–384.
   PubMed Web of Science ®Google Scholar
• Amakura, Y., Tsutsumi, T., Sasaki, K., Nakamura, M., Yoshida, T., Maitani, T. (2008). Influence of food polyphenols on aryl hydrocarbon receptor-signaling pathway estimated by in vitro bioassay. Phytochemistry 69:3117–3130.
   PubMed Web of Science ®Google Scholar
• Aouabdi, S., Gibson, G., Plant, N. (2006). Transcriptional regulation of the PXR gene: identification and characterization of a functional peroxisome proliferator-activated receptor alpha-binding site within the proximal promoter of PXR. Drug Metab Dispos 34:138–144.
   PubMed Web of Science ®Google Scholar
• Ashida, H., Nishiumi, S., Fukuda, I. (2008). An update on the dietary ligands of the AhR. Exp Opin Drug Metab Toxicol 4:1429–1447.
   PubMed Web of Science ®Google Scholar
• Assenat, E., Gerbal-Chaloin, S., Larrey, D., Saric, J., Fabre, J. M., Maurel, P., et al. (2004). Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology 40:951–960.
   PubMed Web of Science ®Google Scholar
• Audet-Walsh, E., Lachaud, A. A., Anderson, A. (2008). The CYP2B2 5′ flank contains a complex glucocorticoid response unit. Biochem Pharmacol 76:1298–1306.
   PubMed Web of Science ®Google Scholar
• Bachleda, P., Dvorak, Z. (2008). Pharmacological inhibitors of JNK and ERK kinases SP600125 and U0126 are not appropriate tools for studies of drug metabolism because they activate aryl hydrocarbon receptor. Gen Physiol Biophys 27:143–145.
   Google Scholar
• Bandiera, S., Weidlich, S., Harth, V., Broede, P., Ko, Y., Friedberg, T. (2005). Proteasomal degradation of human CYP1B1: effect of the Asn453Ser polymorphism on the post-translational regulation of CYP1B1 expression. Mol Pharmacol 67:435–443.
   PubMed Web of Science ®Google Scholar
• Barwick, J. L., Quattrochi, L. C., Mills, A. S., Potenza, C., Tukey, R. H., Guzelian, P. S. (1996). Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes. Mol Pharmacol 50:10–16.
   PubMed Web of Science ®Google Scholar
• Beischlag, T. V., Taylor, R. T., Rose, D. W., Yoon, D., Chen, Y., Lee, W. H., et al. (2004). Recruitment of thyroid hormone receptor/retinoblastoma-interacting protein 230 by the aryl hydrocarbon receptor nuclear translocator is required for the transcriptional response to both dioxin and hypoxia. J Biol Chem 279:54620–54628.
   PubMed Web of Science ®Google Scholar
• Bertilsson, G., Heidrich, J., Svensson, K., Asman, M., Jendeberg, L., Sydow-Backman, M., et al. (1998). Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci U S A 95:12208–12213.
   PubMed Web of Science ®Google Scholar
• Biddie, S. C., Hager, G. L. (2009). Glucocorticoid receptor dynamics and gene regulation. Stress 12:193–205.
   PubMed Web of Science ®Google Scholar
• Bielefeld, K. A., Lee, C., Riddick, D. S. (2008). Regulation of aryl hydrocarbon receptor expression and function by glucocorticoids in mouse hepatoma cells. Drug Metab Dispos 36:543–551.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., Bock-Hennig, B. S. (2010). UDP-glucuronosyltransferases (UGTs): from purification of Ah-receptor-inducible UGT1A6 to coordinate regulation of subsets of CYPs, UGTs, and ABC transporters by nuclear receptors. Drug Metab Rev 42:5–12.
   Web of Science ®Google Scholar
• Bock, K. W., Kohle, C. (2005). Ah receptor- and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis. Biochem Pharmacol 69:1403–1408.
   PubMed Web of Science ®Google Scholar
• Burk, O., Koch, I., Raucy, J., Hustert, E., Eichelbaum, M., Brockmoller, J., et al. (2004). The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR). J Biol Chem 279:38379–38385.
   PubMed Web of Science ®Google Scholar
• Celander, M., Hahn, M. E., Stegeman, J. J. (1996). Cytochromes P450 (CYP) in the Poeciliopsis lucida hepatocellular carcinoma cell line (PLHC-1): dose- and time-dependent glucocorticoid potentiation of CYP1A induction without induction of CYP3A. Arch Biochem Biophys 329:113–122.
   PubMed Web of Science ®Google Scholar
• Chen, Y., Ferguson, S. S., Negishi, M., Goldstein, J. A. (2003). Identification of constitutive androstane receptor and glucocorticoid receptor binding sites in the CYP2C19 promoter. Mol Pharmacol 64:316–324.
   PubMed Web of Science ®Google Scholar
• Chen, Y., Ferguson, S. S., Negishi, M., Goldstein, J. A. (2004). Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor. J Pharmacol Exp Ther 308:495–501.
   PubMed Web of Science ®Google Scholar
• Chen, Y., Goldstein, J. A. (2009). The transcriptional regulation of the human CYP2C genes. Curr Drug Metab 10:567–578.
   PubMed Web of Science ®Google Scholar
• Curi-Pedrosa, R., Daujat, M., Pichard, L., Ourlin, J. C., Clair, P., Gervot,  L., et al. (1994). Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture. J Pharmacol Exp Ther 269:384–392.
   PubMed Web of Science ®Google Scholar
• Daujat, M., Clair, P., Astier, C., Fabre, I., Pineau, T., Yerle, M., et al. (1991) Induction, regulation, and messenger half-life of cytochromes P450 IA1, IA2, and IIIA6 in primary cultures of rabbit hepatocytes. CYP 1A1, 1A2, and 3A6 chromosome location in the rabbit and evidence that post-transcriptional control of gene IA2 does not involve mRNA stabilization. Eur J Biochem 200:501–510.
   PubMedGoogle Scholar
• Daujat, M., Charrasse, S., Fabre, I., Lesca, P., Jounaidi, Y., Larroque,  C., et al. (1996) Induction of CYP1A1 gene by benzimidazole derivatives during Caco-2 cell differentiation. Evidence for an aryl-hydrocarbon receptor-mediated mechanism. Eur J Biochem 237:642–652.
   PubMedGoogle Scholar
• Daujat, M., Peryt, B., Lesca, P., Fourtanier, G., Domergue, J., Maurel,  P. (1992) Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor. Biochem Biophys Res Commun 188:820–825.
   PubMed Web of Science ®Google Scholar
• De Bosscher, K., Vanden Berghe, W., Haegeman, G. (2000). Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J Neuroimmunol 109:16–22.
   PubMed Web of Science ®Google Scholar
• DeFranco, D. B. (2002). Navigating steroid hormone receptors through the nuclear compartment. Mol Endocrinol 16:1449–1455.
   PubMed Web of Science ®Google Scholar
• Delaporte, E., Renton, K. W. (1997). Cytochrome P4501A1 and cytochrome P4501A2 are downregulated at both transcriptional and post-transcriptional levels by conditions resulting in interferon-alpha/beta induction. Life Sci 60:787–796.
   PubMed Web of Science ®Google Scholar
• Denison, M. S., Nagy, S. R. (2003). Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43:309–334.
   PubMed Web of Science ®Google Scholar
• di Masi, A., Marinis, E. D., Ascenzi, P., Marino, M. (2009). Nuclear receptors CAR and PXR: molecular, functional, and biomedical aspects. Mol Aspects Med 30:297–343.
   PubMed Web of Science ®Google Scholar
• Dixit, S. G., Tirona, R. G., Kim, R. B. (2005). Beyond CAR and PXR. Curr Drug Metab 6:385–397.
   PubMed Web of Science ®Google Scholar
• Drocourt, L., Ourlin, J. C., Pascussi, J. M., Maurel, P., Vilarem, M. J. (2002). Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 277:25125–25132.
   PubMed Web of Science ®Google Scholar
• Duma, D., Jewell, C. M., Cidlowski, J. A. (2006). Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol 102:11–21.
   PubMed Web of Science ®Google Scholar
• Duret, C., Daujat-Chavanieu, M., Pascussi, J. M., Pichard-Garcia, L., Balaguer, P., Fabre, J. M. et al. (2006). Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor. Mol Pharmacol 70:329–339.
   PubMed Web of Science ®Google Scholar
• Dvorak, Z., Modriansky, M., Pichard-Garcia, L., Balaguer, P., Vilarem,  M. J., Ulrichova, J. et al. (2003). Colchicine downregulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. Mol Pharmacol 64:160–169.
   PubMed Web of Science ®Google Scholar
• Dvorak, Z., Ulrichova, J., Pichard-Garcia, L., Modriansky, M., Maurel, P. (2002). Comparative effect of colchicine and colchiceine on cytotoxicity and CYP gene expression in primary human hepatocytes. Toxicol In Vitro 16:219–227.
   PubMed Web of Science ®Google Scholar
• Dvorak, Z., Vrzal, R., Henklova, P., Jancova, P., Anzenbacherova, E., Maurel, P., et al. (2008a). JNK inhibitor SP600125 is a partial agonist of human aryl hydrocarbon receptor and induces CYP1A1 and CYP1A2 genes in primary human hepatocytes. Biochem Pharmacol 75:580–588.
   PubMed Web of Science ®Google Scholar
• Dvorak, Z., Vrzal, R., Pavek, P., Ulrichova, J. (2008b). An evidence for regulatory cross-talk between aryl hydrocarbon receptor and glucocorticoid receptor in HepG2 cells. Physiol Res 57:427–435.
   PubMed Web of Science ®Google Scholar
• El-Sankary, W., Bombail, V., Gibson, G. G., Plant, N. (2002). Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element. Drug Metab Dispos 30:1029–1034.
   PubMed Web of Science ®Google Scholar
• El-Sankary, W., Plant, N. J., Gibson, G. G., Moore, D. J. (2000). Regulation of the CYP3A4 gene by hydrocortisone and xenobiotics: role of the glucocorticoid and pregnane X receptors. Drug Metab Dispos 28:493–496.
   PubMed Web of Science ®Google Scholar
• Elbekai, R. H., El-Kadi, A. O. (2007). Transcriptional activation and post-transcriptional modification of Cyp1a1 by arsenite, cadmium, and chromium. Toxicol Lett 172:106–119.
   PubMed Web of Science ®Google Scholar
• Esser, C. (2009). The immune phenotype of AhR null mouse mutants: not a simple mirror of xenobiotic receptor overactivation. Biochem Pharmacol 77:597–607.
   PubMed Web of Science ®Google Scholar
• Esser, C., Rannug, A., Stockinger, B. (2009). The aryl hydrocarbon receptor in immunity. Trends Immunol 30:447–454.
   PubMed Web of Science ®Google Scholar
• Fallone, F., Villard, P. H., Decome, L., Seree, E., Meo, M., Chacon,  C., et al. (2005). PPARalpha activation potentiates AhR-induced CYP1A1 expression. Toxicology 216:122–128.
   PubMed Web of Science ®Google Scholar
• Fallone, F., Villard, P. H., Seree, E., Rimet, O., Nguyen, Q. B., Bourgarel-Rey, V., et al. (2004). Retinoids repress Ah receptor CYP1A1 induction pathway through the SMRT corepressor. Biochem Biophys Res Commun 322:551–556.
   PubMed Web of Science ®Google Scholar
• Faucette, S. R., Sueyoshi, T., Smith, C. M., Negishi, M., Lecluyse, E. L., Wang, H. (2006). Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor. J Pharmacol Exp Ther 317:1200–1209.
   PubMed Web of Science ®Google Scholar
• Faucette, S. R., Wang, H., Hamilton, G. A., Jolley, S. L., Gilbert, D., Lindley, C., et al. (2004). Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers. Drug Metab Dispos 32:348–358.
   PubMed Web of Science ®Google Scholar
• Faucette, S. R., Zhang, T. C., Moore, R., Sueyoshi, T., Omiecinski, C. J., Lecluyse, E. L., et al. (2007). Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers. J Pharmacol Exp Ther 320:72–80.
   PubMed Web of Science ®Google Scholar
• Ferguson, S. S., Chen, Y., Lecluyse, E. L., Negishi, M., Goldstein, J. A. (2005). Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4alpha. Mol Pharmacol 68:747–757.
   PubMed Web of Science ®Google Scholar
• Ferguson, S. S., Lecluyse, E. L., Negishi, M., Goldstein, J. A. (2002). Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site. Mol Pharmacol 62:737–746.
   PubMed Web of Science ®Google Scholar
• Forman, B. M., Tzameli, I., Choi, H. S., Chen, J., Simha, D., Seol, W., et al. (1998). Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature 395:612–615.
   PubMed Web of Science ®Google Scholar
• Freeman, J. E., Wolf, C. R. (1994). Evidence against a role for serine 129 in determining murine cytochrome P450 Cyp2e-1 protein levels. Biochemistry 33:13963–13966.
   PubMed Web of Science ®Google Scholar
• Froy, O. (2009). Cytochrome P450 and the biological clock in mammals. Curr Drug Metab 10:104–115.
   PubMed Web of Science ®Google Scholar
• Fukuda, I., Mukai, R., Kawase, M., Yoshida, K., Ashida, H. (2007). Interaction between the aryl hydrocarbon receptor and its antagonists, flavonoids. Biochem Biophys Res Commun 359:822–827.
   PubMed Web of Science ®Google Scholar
• Galliher-Beckley, A. J., Cidlowski, J. A. (2009). Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease. IUBMB Life 61:979–986.
   PubMed Web of Science ®Google Scholar
• Gasiewicz, T. A., Henry, E. C., Collins, L. L. (2008). Expression and activity of aryl hydrocarbon receptors in development and cancer. Crit Rev Eukaryot Gene Expr 18:279–321.
   PubMed Web of Science ®Google Scholar
• Gatti, R., Antonelli, G., Prearo, M., Spinella, P., Cappellin, E., De Palo,  E. F. (2009). Cortisol assays and diagnostic laboratory procedures in human biological fluids. Clin Biochem 42:1205–1217.
   PubMed Web of Science ®Google Scholar
• George, A. A., Schiltz, R. L., Hager, G. L. (2009). Dynamic access of the glucocorticoid receptor to response elements in chromatin. Int J Biochem Cell Biol 41:214–224.
   PubMed Web of Science ®Google Scholar
• Gerbal-Chaloin, S., Daujat, M., Pascussi, J. M., Pichard-Garcia, L., Vilarem, M. J., Maurel, P. (2002). Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor. J Biol Chem 277:209–217.
   PubMed Web of Science ®Google Scholar
• Gerbal-Chaloin, S., Pascussi, J. M., Pichard-Garcia, L., Daujat, M., Waechter, F., Fabre, J. M., et al. (2001). Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metab Dispos 29:242–251.
   PubMed Web of Science ®Google Scholar
• Gibson, G. G., Plant, N. J., Swales, K. E., Ayrton, A., El-Sankary, W. (2002). Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man. Xenobiotica 32:165–206.
   PubMed Web of Science ®Google Scholar
• Goodwin, B., Moore, L. B., Stoltz, C. M., McKee, D. D., Kliewer, S. A. (2001). Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol Pharmacol 60:427–431.
   PubMed Web of Science ®Google Scholar
• Gottlicher, M., Heck, S., Herrlich, P. (1998). Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med 76:480–489.
   PubMed Web of Science ®Google Scholar
• Gouedard, C., Barouki, R., Morel, Y. (2004a). Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol Cell Biol 24:5209–5222.
   PubMed Web of Science ®Google Scholar
• Gouedard, C., Barouki, R., Morel, Y. (2004b). Induction of the paraoxonase-1 gene expression by resveratrol. Arterioscler Thromb Vasc Biol 24:2378–2383.
   PubMed Web of Science ®Google Scholar
• Graham, M. J., Lake, B. G. (2008). Induction of drug metabolism: species differences and toxicological relevance. Toxicology 254:184–191.
   PubMed Web of Science ®Google Scholar
• Gross, K. L., Cidlowski, J. A. (2008). Tissue-specific glucocorticoid action: a family affair. Trends Endocrinol Metab 19:331–339.
   PubMed Web of Science ®Google Scholar
• Guenthner, T. M., Nebert, D. W. (1977). Cytosolic receptor for aryl hydrocarbon hydroxylase induction by polycyclic aromatic compounds. Evidence for structural and regulatory variants among established cell cultured lines. J Biol Chem 252:8981–8989.
   PubMed Web of Science ®Google Scholar
• Harper, P. A., Riddick, D. S., Okey, A. B. (2006). Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor. Biochem Pharmacol 72:267–279.
   PubMed Web of Science ®Google Scholar
• Head, J. L., Lawrence, B. P. (2009). The aryl hydrocarbon receptor is a modulator of antiviral immunity. Biochem Pharmacol 77:642–653.
   PubMed Web of Science ®Google Scholar
• Herrlich, P. (2001). Cross-talk between glucocorticoid receptor and AP-1. Oncogene 20:2465–2475.
   PubMed Web of Science ®Google Scholar
• Honkakoski, P., Zelko, I., Sueyoshi, T., Negishi, M. (1998). The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol 18:5652–5658.
   PubMed Web of Science ®Google Scholar
• Huan, J. Y., Streicher, J. M., Bleyle, L. A., Koop, D. R. (2004). Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells. Toxicol Appl Pharmacol 199:332–343.
   PubMed Web of Science ®Google Scholar
• Huss, J. M., Kasper, C. B. (1998). Nuclear receptor involvement in the regulation of rat cytochrome P450 3A23 expression. J Biol Chem 273:16155–16162.
   PubMed Web of Science ®Google Scholar
• Igarashi, M., Yogiashi, Y., Mihara, M., Takada, I., Kitagawa, H., Kato,  S. (2007). Vitamin K induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene. Mol Cell Biol 27:7947–7954.
   PubMed Web of Science ®Google Scholar
• Itoh, M., Nakajima, M., Higashi, E., Yoshida, R., Nagata, K., Yamazoe,  Y., et al. (2006). Induction of human CYP2A6 is mediated by the pregnane X receptor with peroxisome proliferator-activated receptor-gamma coactivator 1alpha. J Pharmacol Exp Ther 319:693–702.
   PubMed Web of Science ®Google Scholar
• Jaiswal, A. K., Haaparanta, T., Luc, P. V., Schembri, J., Adesnik, M. (1990). Glucocorticoid regulation of a phenobarbital-inducible cytochrome P-450 gene: the presence of a functional glucocorticoid response element in the 5′-flanking region of the CYP2B2 gene. Nucleic Acids Res 18:4237–4242.
   PubMed Web of Science ®Google Scholar
• Kakizaki, S., Yamazaki, Y., Takizawa, D., Negishi, M. (2008). New insights on the xenobiotic-sensing nuclear receptors in liver diseases—CAR and PXR. Curr Drug Metab 9:614–621.
   PubMed Web of Science ®Google Scholar
• Klaassen, C. D., Slitt, A. L. (2005). Regulation of hepatic transporters by xenobiotic receptors. Curr Drug Metab 6:309–328.
   PubMed Web of Science ®Google Scholar
• Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., et al. (1998). An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92:73–82.
   PubMed Web of Science ®Google Scholar
• Kocarek, T. A., Mercer-Haines, N. A. (2002). Squalestatin 1-inducible expression of rat CYP2B: evidence that an endogenous isoprenoid is an activator of the constitutive androstane receptor. Mol Pharmacol 62:1177–1186.
   PubMed Web of Science ®Google Scholar
• Kohalmy, K., Tamasi, V., Kobori, L., Sarvary, E., Pascussi, J. M., Porrogi,  P., et al. (2007). Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor. Drug Metab Dispos 35:1495–1501.
   PubMed Web of Science ®Google Scholar
• Kohle, C., Bock, K. W. (2009). Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor, and constitutive androstane receptor. Biochem Pharmacol 77:689–699.
   PubMed Web of Science ®Google Scholar
• Konno, Y., Negishi, M., Kodama, S. (2008). The roles of nuclear receptors CAR and PXR in hepatic energy metabolism. Drug Metab Pharmacokinet 23:8–13.
   PubMed Web of Science ®Google Scholar
• Lam, S., Partovi, N., Ting, L. S., Ensom, M. H. (2008). Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction? Ann Pharmacother 42:1037–1047.
   PubMed Web of Science ®Google Scholar
• Landes, N., Pfluger, P., Kluth, D., Birringer, M., Ruhl, R., Bol, G. F., et al. (2003). Vitamin E activates gene expression via the pregnane X receptor. Biochem Pharmacol 65:269–273.
   PubMed Web of Science ®Google Scholar
• Lee, C. M., Kim, B. Y., Li, L., Morgan, E. T. (2008). Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins. J Biol Chem 283:889–898.
   PubMed Web of Science ®Google Scholar
• Lekas, P., Tin, K. L., Lee, C., Prokipcak, R. D. (2000). The human cytochrome P450, 1A1 mRNA, is rapidly degraded in HepG2 cells. Arch Biochem Biophys 384:311–318.
   PubMed Web of Science ®Google Scholar
• Linder, M. W., Falkner, K. C., Srinivasan, G., Hines, R. N., Prough, R. A. (1999). Role of canonical glucocorticoid responsive elements in modulating expression of genes regulated by the arylhydrocarbon receptor. Drug Metab Rev 31:247–271.
   PubMed Web of Science ®Google Scholar
• Lu, N. Z., Cidlowski, J. A. (2006). Glucocorticoid receptor isoforms generate transcription specificity. Trends Cell Biol 16:301–307.
   PubMed Web of Science ®Google Scholar
• Luo, G., Guenthner, T., Gan, L. S., Humphreys, W. G. (2004). CYP3A4 induction by xenobiotics: biochemistry, experimental methods, and impact on drug discovery and development. Curr Drug Metab 5:483–505.
   PubMed Web of Science ®Google Scholar
• Marlowe, J. L., Puga, A. (2005). Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J Cell Biochem 96:1174–1184.
   PubMed Web of Science ®Google Scholar
• Martinez-Jimenez, C. P., Jover, R., Donato, M. T., Castell, J. V., Gomez-Lechon, M. J. (2007). Transcriptional regulation and expression of CYP3A4 in hepatocytes. Curr Drug Metab 8:185–194.
   PubMed Web of Science ®Google Scholar
• Martini, R., Ingelman-Sundberg, M., Murray, M. (1997). Pretranslational and post-translational regulation of rat hepatic CYPs 3A2 and 2E1 by disulfiram. Biochem Pharmacol 54:1323–1329.
   PubMed Web of Science ®Google Scholar
• Mathis, J. M., Prough, R. A., Hines, R. N., Bresnick, E., Simpson, E. R. (1986a). Regulation of cytochrome P-450c by glucocorticoids and polycyclic aromatic hydrocarbons in cultured fetal rat hepatocytes. Arch Biochem Biophys 246:439–448.
   PubMed Web of Science ®Google Scholar
• Mathis, J. M., Prough, R. A., Simpson, E. R. (1986b). Synergistic induction of monooxygenase activity by glucocorticoids and polycyclic aromatic hydrocarbons in human fetal hepatocytes in primary monolayer culture. Arch Biochem Biophys 244:650–661.
   PubMed Web of Science ®Google Scholar
• Matsubara, T., Yoshinari, K., Aoyama, K., Sugawara, M., Sekiya, Y., Nagata, K., et al. (2008). Role of vitamin D receptor in the lithocholic acid-mediated CYP3A induction in vitro and in vivo. Drug Metab Dispos 36:2058–2063.
   PubMed Web of Science ®Google Scholar
• Mattingly, C. J., Toscano, W. A. (2001). Post-transcriptional silencing of cytochrome P4501A1 (CYP1A1) during zebrafish (Danio rerio) development. Dev Dyn 222:645–654.
   PubMed Web of Science ®Google Scholar
• Miller, G. E., Chen, E., Zhou, E. S. (2007). If it goes up, must it come down? Chronic stress and the hypothalamic–pituitary–adrenocortical axis in humans. Psychol Bull 133:25–45.
   PubMed Web of Science ®Google Scholar
• Monostory, K., Kohalmy, K., Prough, R. A., Kobori, L., Vereczkey, L. (2005). The effect of synthetic glucocorticoid, dexamethasone on CYP1A1 inducibility in adult rat and human hepatocytes. FEBS Lett 579:229–235.
   PubMed Web of Science ®Google Scholar
• Monostory, K., Pascussi, J. M., Kobori, L., Dvorak, Z. (2009). Hormonal regulation of CYP1A expression. Drug Metab Rev 41:547–572.
   PubMed Web of Science ®Google Scholar
• Moon, Y. J., Wang, X., Morris, M. E. (2006). Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 20:187–210.
   PubMed Web of Science ®Google Scholar
• Moreau, A., Teruel, C., Beylot, M., Albalea, V., Tamasi, V., Umbdenstock, T., et al. (2009). A novel pregnane X receptor and S14-mediated lipogenic pathway in human hepatocyte. Hepatology 49:2068–2079.
   PubMed Web of Science ®Google Scholar
• Moreau, A., Vilarem, M. J., Maurel, P., Pascussi, J. M. (2008). Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response. Mol Pharm 5:35–41.
   PubMed Web of Science ®Google Scholar
• Morishima, Y., Peng, H. M., Lin, H. L., Hollenberg, P. F., Sunahara,  R. K., Osawa, Y., et al. (2005). Regulation of cytochrome P450 2E1 by heat shock protein 90–dependent stabilization and CHIP-dependent proteasomal degradation. Biochemistry 44:16333–16340.
   PubMed Web of Science ®Google Scholar
• Murphy, K. A., Quadro, L., White, L. A. (2007). The intersection between the aryl hydrocarbon receptor (AhR)- and retinoic acid-signaling pathways. Vitam Horm 75:33–67.
   PubMed Web of Science ®Google Scholar
• Murray, I. A., Perdew, G. H. (2008). Omeprazole stimulates the induction of human insulin-like growth factor binding protein-1 through aryl hydrocarbon receptor activation. J Pharmacol Exp Ther 324:1102–1110.
   PubMed Web of Science ®Google Scholar
• Nguyen, L. P., Bradfield, C. A. (2008). The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 21:102–116.
   PubMed Web of Science ®Google Scholar
• Ogg, M. S., Williams, J. M., Tarbit, M., Goldfarb, P. S., Gray, T. J., Gibson,  G. G. (1999). A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene in vitro. Xenobiotica 29:269–279.
   PubMed Web of Science ®Google Scholar
• Ohno, M., Yamaguchi, I., Ito, T., Saiki, K., Yamamoto, I., Azuma, J. (2000). Circadian variation of the urinary 6beta-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity. Eur J Clin Pharmacol 55:861–865.
   PubMed Web of Science ®Google Scholar
• Ohtake, F., Fujii-Kuriyama, Y., Kato, S. (2009). AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions. Biochem Pharmacol 77:474–484.
   PubMed Web of Science ®Google Scholar
• Onica, T., Nichols, K., Larin, M., Ng, L., Maslen, A., Dvorak, Z., et al. (2008). Dexamethasone-mediated upregulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4{alpha} to the proximal promoter. Mol Pharmacol 73:451–460.
   PubMed Web of Science ®Google Scholar
• Pan, J., Hong, J. Y., Yang, C. S. (1992). Post-transcriptional regulation of mouse renal cytochrome P450 2E1 by testosterone. Arch Biochem Biophys 299:110–115.
   PubMed Web of Science ®Google Scholar
• Pascussi, J. M., Busson-Le Coniat, M., Maurel, P., Vilarem, M. J. (2003a). Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response element. Mol Endocrinol 17:42–55.
   PubMed Web of Science ®Google Scholar
• Pascussi, J. M., Drocourt, L., Fabre, J. M., Maurel, P., Vilarem, M. J. (2000a). Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol Pharmacol 58:361–372.
   PubMed Web of Science ®Google Scholar
• Pascussi, J. M., Drocourt, L., Gerbal-Chaloin, S., Fabre, J. M., Maurel,  P., Vilarem, M. J. (2001). Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. Eur J Biochem 268:6346–6358.
   PubMedGoogle Scholar
• Pascussi, J. M., Dvorak, Z., Gerbal-Chaloin, S., Assenat, E., Maurel, P., Vilarem, M. J. (2003b). Pathophysiological factors affecting CAR gene expression. Drug Metab Rev 35:255–268.
   PubMed Web of Science ®Google Scholar
• Pascussi, J. M., Gerbal-Chaloin, S., Drocourt, L., Maurel, P., Vilarem,  M. J. (2003c). The expression of CYP2B6, CYP2C9, and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 1619:243–253.
   PubMed Web of Science ®Google Scholar
• Pascussi, J. M., Gerbal-Chaloin, S., Duret, C., Daujat-Chavanieu, M., Vilarem, M. J., Maurel, P. (2008). The tangle of nuclear receptors that controls xenobiotic metabolism and transport: cross-talk and consequences. Annu Rev Pharmacol Toxicol 48:1–32.
   PubMed Web of Science ®Google Scholar
• Pascussi, J. M., Gerbal-Chaloin, S., Fabre, J. M., Maurel, P., Vilarem,  M. J. (2000b). Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol Pharmacol 58:1441–1450.
   PubMed Web of Science ®Google Scholar
• Pascussi, J. M., Gerbal-Chaloin, S., Pichard-Garcia, L., Daujat, M., Fabre, J. M., Maurel, P., et al. (2000c). Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem Biophys Res Commun 274:707–713.
   PubMed Web of Science ®Google Scholar
• Pascussi, J. M., Jounaidi, Y., Drocourt, L., Domergue, J., Balabaud, C., Maurel, P., et al. (1999). Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 promoter gene. Biochem Biophys Res Commun 260:377–381.
   PubMed Web of Science ®Google Scholar
• Pavek, P., Cerveny, L., Svecova, L., Brysch, M., Libra, A., Vrzal, R., et al. (2007). Examination of glucocorticoid receptor alpha-mediated transcriptional regulation of P-glycoprotein, CYP3A4, and CYP2C9 genes in placental trophoblast cell lines. Placenta 28:1004–1011.
   PubMed Web of Science ®Google Scholar
• Pavek, P., Dvorak, Z. (2008). Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr Drug Metab, 9, 129–43.
   PubMed Web of Science ®Google Scholar
• Pavek, P., Pospechova, K., Svecova, L., Syrova, Z., Stejskalova, L., Blazkova, J., et al. (2010). Intestinal cell-specific vitamin D receptor (VDR)-mediated transcriptional regulation of CYP3A4 gene. Biochem Pharmacol 79:277–287.
   PubMed Web of Science ®Google Scholar
• Pereira, T. M., Carlstedt-Duke, J., Lechner, M. C., Gustafsson, J. A. (1998). Identification of a functional glucocorticoid response element in the CYP3A1/IGC2 gene. DNA Cell Biol 17:39–49.
   PubMed Web of Science ®Google Scholar
• Puga, A., Ma, C., Marlowe, J. L. (2009). The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol 77:713–722.
   PubMed Web of Science ®Google Scholar
• Raffalli-Mathieu, F., Geneste, O., Lang, M. A. (1997). Characterization of two nuclear proteins that interact with cytochrome P-450 1A2 mRNA. Regulation of RNA binding and possible role in the expression of the Cyp1a2 gene. Eur J Biochem 245:17–24.
   PubMedGoogle Scholar
• Ray, S., Swanson, H. I. (2009). Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: a tumor promoting event? Biochem Pharmacol 77:681–688.
   PubMed Web of Science ®Google Scholar
• Reichardt, H. M., Kaestner, K. H., Wessely, O., Gass, P., Schmid, W., Schutz, G. (1998). Analysis of glucocorticoid signalling by gene targeting. J Steroid Biochem Mol Biol 65:111–115.
   PubMed Web of Science ®Google Scholar
• Revel, A., Raanani, H., Younglai, E., Xu, J., Rogers, I., Han, R., et al. (2003). Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J Appl Toxicol 23:255–261.
   PubMed Web of Science ®Google Scholar
• Revollo, J. R., Cidlowski, J. A. (2009). Mechanisms generating diversity in glucocorticoid receptor signaling. Ann N Y Acad Sci 1179:167–178.
   PubMed Web of Science ®Google Scholar
• Roth, A., Looser, R., Kaufmann, M., Blattler, S. M., Rencurel, F., Huang, W., et al. (2008). Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression. Mol Pharmacol 73:1282–1289.
   PubMed Web of Science ®Google Scholar
• RuhL, R. (2005). Induction of PXR-mediated metabolism by beta-carotene. Biochim Biophys Acta 1740:162–169.
   PubMed Web of Science ®Google Scholar
• Runge-Morris, M., Kocarek, T. A. (2005). Regulation of sulfotransferases by xenobiotic receptors. Curr Drug Metab 6:299–307.
   PubMed Web of Science ®Google Scholar
• Rushmore, T. H., Kong, A. N. (2002). Pharmacogenomics, regulation, and signaling pathways of phase I and II drug-metabolizing enzymes. Curr Drug Metab 3:481–490.
   PubMed Web of Science ®Google Scholar
• Safe, S., Wormke, M. (2003). Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. Chem Res Toxicol 16:807–816.
   PubMed Web of Science ®Google Scholar
• Sahi, J., Shord, S. S., Lindley, C., Ferguson, S., LeCluyse, E. L. (2009). Regulation of cytochrome P450 2C9 expression in primary cultures of human hepatocytes. J Biochem Mol Toxicol 23:43–58.
   PubMed Web of Science ®Google Scholar
• Sapse, A. T. (1997). Cortisol, high cortisol diseases, and anticortisol therapy. Psychoneuroendocrinology 22(Suppl 1):S3–S10.
   PubMedGoogle Scholar
• Seree, E., Villard, P. H., Pascussi, J. M., Pineau, T., Maurel, P., Nguyen, Q. B., et al. (2004). Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites. Gastroenterology 127:1436–1445.
   PubMed Web of Science ®Google Scholar
• Shimba, S., Watabe, Y. (2009). Cross-talk between the AHR signaling pathway and circadian rhythm. Biochem Pharmacol 77:560–565.
   PubMed Web of Science ®Google Scholar
• Schuetz, E. G., Schmid, W., Schutz, G., Brimer, C., Yasuda, K., Kamataki, T., et al. (2000). The glucocorticoid receptor is essential for induction of cytochrome P-4502B by steroids, but not for drug or steroid induction of CYP3A or P-450 reductase, in mouse liver. Drug Metab Dispos 28:268–278.
   PubMed Web of Science ®Google Scholar
• Schuetz, E. G., Wrighton, S. A., Barwick, J. L., Guzelian, P. S. (1984). Induction of cytochrome P-450 by glucocorticoids in rat liver. I. Evidence that glucocorticoids and pregnenolone 16 alpha-carbonitrile regulate de novo synthesis of a common form of cytochrome P-450 in cultures of adult rat hepatocytes and in the liver in vivo. J Biol Chem 259:1999–2006.
   PubMed Web of Science ®Google Scholar
• Schuetz, J. D., Schuetz, E. G., Thottassery, J. V., Guzelian, P. S., Strom,  S., Sun, D. (1996). Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells. Mol Pharmacol 49:63–72.
   PubMed Web of Science ®Google Scholar
• Song, I. H., Buttgereit, F. (2006). Nongenomic glucocorticoid effects to provide the basis for new drug developments. Mol Cell Endocrinol 246:142–146.
   PubMed Web of Science ®Google Scholar
• Sonneveld, E., Jonas, A., Meijer, O. C., Brouwer, A., Van Der Burg, B. (2007). Glucocorticoid-enhanced expression of dioxin target genes through regulation of the rat aryl hydrocarbon receptor. Toxicol Sci 99:455–469.
   PubMed Web of Science ®Google Scholar
• Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LATOUR, A. et al. (2001). The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A 98:3369–3374.
   PubMed Web of Science ®Google Scholar
• Steineger, H. H., Arntsen, B. M., Spydevold, O., Sorensen, H. N. (1997). Retinoid X receptor (RXR alpha) gene expression is regulated by fatty acids and dexamethasone in hepatic cells. Biochimie 79:107–110.
   PubMed Web of Science ®Google Scholar
• Stoltz, C., Anderson, A. (1999). Positive regulation of the rat CYP2B2 phenobarbital response unit by the nuclear receptor hexamer half-site.nuclear factor 1 complex. Biochem Pharmacol 57:1073–1076.
   PubMed Web of Science ®Google Scholar
• Sutter-Dub, M. T. (2002). Rapid nongenomic and genomic responses to progestogens, estrogens, and glucocorticoids in the endocrine pancreatic B cell, the adipocyte, and other cell types. Steroids 67:77–93.
   PubMed Web of Science ®Google Scholar
• Tabb, M. M., Sun, A., Zhou, C., Grun, F., Errandi, J., Romero, K., et al. (2003). Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 278:43919–43927.
   PubMed Web of Science ®Google Scholar
• Tirona, R. G., Kim, R. B. (2005). Nuclear receptors and drug disposition gene regulation. J Pharm Sci 94:1169–1186.
   PubMed Web of Science ®Google Scholar
• Traber, M. G. (2004). Vitamin E, nuclear receptors, and xenobiotic metabolism. Arch Biochem Biophys 423:6–11.
   PubMed Web of Science ®Google Scholar
• Urquhart, B. L., Tirona, R. G., Kim, R. B. (2007). Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J Clin Pharmacol 47:566–578.
   PubMed Web of Science ®Google Scholar
• Villikka, K., Kivisto, K. T., Neuvonen, P. J. (1998). The effect of dexamethasone on the pharmacokinetics of triazolam. Pharmacol Toxicol 83:135–138.
   PubMedGoogle Scholar
• Vrzal, R., Daujat-Chavanieu, M., Pascussi, J. M., Ulrichova, J., Maurel,  P., Dvorak, Z. (2008). Microtubules-interfering agents restrict aryl hydrocarbon receptor-mediated CYP1A2 induction in primary cultures of human hepatocytes via c-jun-N-terminal kinase and glucocorticoid receptor. Eur J Pharmacol 581:244–254.
   PubMed Web of Science ®Google Scholar
• Vrzal, R., Stejskalova, L., Monostory, K., Maurel, P., Bachleda, P., Pavek, P., et al. (2009). Dexamethasone controls aryl hydrocarbon receptor (AhR)-mediated CYP1A1 and CYP1A2 expression and activity in primary cultures of human hepatocytes. Chem Biol Interact 179:288–296.
   PubMed Web of Science ®Google Scholar
• Vrzal, R., Ulrichova, J., Dvorak, Z., Pavek, P. (2007). Glucocorticoid receptor functions in HeLa cells are perturbed by 2,3,8,9-tetrachlorodibenzo-p-dioxin (TCDD). Drug Metab Lett 1:311–314.
   PubMedGoogle Scholar
• Vrzal, R., Zdarilova, A., Ulrichova, J., Blaha, L., Giesy, J. P., Dvorak, Z. (2005). Activation of the aryl hydrocarbon receptor by berberine in HepG2 and H4IIE cells: biphasic effect on CYP1A1. Biochem Pharmacol 70:925–936.
   PubMed Web of Science ®Google Scholar
• Wada, T., Gao, J., Xie, W. (2009). PXR and CAR in energy metabolism. Trends Endocrinol Metab 20:273–279.
   PubMed Web of Science ®Google Scholar
• Wallace, A. D., Cidlowski, J. A. (2001). Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem 276:42714–42721.
   PubMed Web of Science ®Google Scholar
• Wan, Y. J., Wang, L., Wu, T. C. (1994). Dexamethasone increases the expression of retinoid X receptor genes in rat hepatoma cell lines. Lab Invest 70:547–552.
   PubMed Web of Science ®Google Scholar
• Wang, H., Faucette, S., Moore, R., Sueyoshi, T., Negishi, M., LeCluyse,  E. (2004). Human constitutive androstane receptor mediates induction of CYP2B6 gene expression by phenytoin. J Biol Chem 279:29295–29301.
   PubMed Web of Science ®Google Scholar
• Wang, H., Faucette, S. R., Gilbert, D., Jolley, S. L., Sueyoshi, T., Negishi, M., et al. (2003). Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes. Drug Metab Dispos 31:620–630.
   PubMed Web of Science ®Google Scholar
• Wang, K., Chen, S., Xie, W., Wan, Y. J. (2008). Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathway. Biochem Pharmacol 75:2204–2213.
   PubMed Web of Science ®Google Scholar
• Watkins, P. B., Murray, S. A., Winkelman, L. G., Heuman, D. M., Wrighton, S. A., Guzelian, P. S. (1989). Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients. J Clin Invest 83:688–697.
   PubMed Web of Science ®Google Scholar
• Watkins, P. B., Wrighton, S. A., Maurel, P., Schuetz, E. G., Mendez-Picon, G., Parker, G. A., et al. (1985). Identification of an inducible form of cytochrome P-450 in human liver. Proc Natl Acad Sci U S A 82:6310–6314.
   PubMed Web of Science ®Google Scholar
• Wrighton, S. A., Schuetz, E. G., Watkins, P. B., Maurel, P., Barwick, J., Bailey, B. S., et al. (1985). Demonstration in multiple species of inducible hepatic cytochromes P-450 and their mRNAs related to the glucocorticoid-inducible cytochrome P-450 of the rat. Mol Pharmacol 28:312–321.
   PubMed Web of Science ®Google Scholar
• Xu, C., Li, C. Y., Kong, A. N. (2005). Induction of phase I, II, and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28:249–268.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, S., Murata, Y., Nagaya, T., Hayashi, Y., Ohmori, S., Nimura,  Y., et al. (1999). Glucocorticoids increase retinoid-X receptor alpha (RXRalpha) expression and enhance thyroid hormone action in primary cultured rat hepatocytes. J Mol Endocrinol 22:81–90.
   PubMed Web of Science ®Google Scholar
• Yoshinari, K., Ueda, R., Kusano, K., Yoshimura, T., Nagata, K., Yamazoe, Y. (2008). Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements. Biochem Pharmacol 76:139–145.
   PubMed Web of Science ®Google Scholar
• Yudt, M. R., Cidlowski, J. A. (2001). Molecular identification and characterization of a and b forms of the glucocorticoid receptor. Mol Endocrinol 15:1093–1103.
   PubMed Web of Science ®Google Scholar
• Zangar, R. C., Bollinger, N., Verma, S., Karin, N. J., Lu, Y. (2008). The nuclear factor-kappa B pathway regulates cytochrome P450 3A4 protein stability. Mol Pharmacol 73:1652–1658.
   PubMed Web of Science ®Google Scholar
• Zangar, R. C., Kimzey, A. L., Okita, J. R., Wunschel, D. S., Edwards, R. J., Kim, H., et al. (2002). Cytochrome P450 3A conjugation to ubiquitin in a process distinct from classical ubiquitination pathway. Mol Pharmacol 61:892–904.
   PubMed Web of Science ®Google Scholar
• Zhou, J., Zhang, J., Xie, W. (2005). Xenobiotic nuclear receptor-mediated regulation of UDP-glucuronosyl-transferases. Curr Drug Metab 6:289–298.
   PubMed Web of Science ®Google Scholar
• Zilliacus, J., Wright, A. P., Carlstedt-Duke, J., Gustafsson, J. A. (1995). Structural determinants of DNA-binding specificity by steroid receptors. Mol Endocrinol 9:389–400.
   PubMed Web of Science ®Google Scholar